QC
IONS icon

Quent Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Quent Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.43K Hold
99
– – ﹤0.01% 1212
2025
Q4 		$7.83K Buy
99
+1
+1% +$75 ﹤0.01% 1200
2025
Q3 		$6.41K Buy
+98
New +$4.79K ﹤0.01% 1101
2025
Q2 		– Sell
-53
Closed -$1.6K – 758
2025
Q1 		$1.6K Sell
53
-21
-28% -$688 ﹤0.01% 1163
2024
Q4 		$2.59K Hold
74
– – ﹤0.01% 1136
2024
Q3 		$2.96K Hold
74
– – ﹤0.01% 1185
2024
Q2 		$3.53K Buy
74
+19
+35% +$779 ﹤0.01% 1144
2024
Q1 		$2.38K Buy
55
+34
+162% +$1.62K ﹤0.01% 1208
2023
Q4 		$1.06K Buy
+21
New +$1.01K ﹤0.01% 1256

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quent Capital's IONS Position: Q1 2026 in Review

Quent Capital held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 99 shares worth $7.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

Quent Capital first reported a position in IONS in Q4 2023 and has held it in 9 quarters since. The position peaked at $7.83K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Quent Capital held 99 shares of Ionis Pharmaceuticals worth $7.43K as of Q1 2026.
  • Quent Capital left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1212 holding.
  • Quent Capital first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • Quent Capital's Ionis Pharmaceuticals position peaked at $7.83K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.